Senior Principal Scientist
DSTL, United Kingdom
Riccardo D’Elia has over 20 years research and development experience covering both pre and post exposure therapeutics. The focus of studies has primarily been on host-pathogen interactions, involving bacteria, viruses, toxins and parasites.